Physician profile
Jay Schecter
NPI 1871658054
$2,415.68
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,037 · 2020: $365 · 2021: $13.40.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $247.24 | 2019-2020 | |
| Genzyme Corporation | $162.07 | 2019-2020 | |
| Greenwich Biosciences, INC. | $139.66 | 2019-2020 | |
| Allergan, INC. | $136.32 | 2019-2020 | |
| Ucb, INC. | $135.62 | 2019-2020 | |
| Ge Healthcare | $118.54 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $110.39 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $96.89 | 2019-2020 | |
| Amgen INC. | $91.76 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $84.22 | 2019 | |
| Biogen, INC. | $76.51 | 2019-2020 | |
| Merz North America, INC. | $73.00 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $66.42 | 2019 | |
| Acorda Therapeutics, INC | $63.10 | 2019 | |
| Abbvie INC. | $62.56 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $62.49 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $61.74 | 2019-2020 | |
| Genentech USA, INC. | $61.04 | 2019-2020 | |
| Emd Serono, INC. | $50.20 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $46.96 | 2019 | |
| Mdd US Operations, LLC | $45.13 | 2019 | |
| Lundbeck LLC | $44.75 | 2019 | |
| Csl Behring | $42.03 | 2019-2020 | |
| Livanova USA, INC. | $41.47 | 2019-2020 | |
| Tersera Therapeutics LLC | $41.18 | 2019 | |
| Amneal Pharmaceuticals LLC | $39.38 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $38.07 | 2019-2020 | |
| Eisai INC. | $36.59 | 2019-2020 | |
| Lilly USA, LLC | $34.02 | 2019 | |
| Arbor Pharmaceuticals, INC. | $30.03 | 2019-2020 | |
| Pfizer INC. | $26.74 | 2019 | |
| Jazz Pharmaceuticals INC. | $13.40 | 2021 | |
| Kyowa Kirin, INC. | $12.59 | 2019 | |
| Avanir Pharmaceuticals, INC. | $12.25 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.32 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Schecter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.